How Open Data Standards Enable Artificial Intelligence in Pharma

May 6, 2021
8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST
Duration: 60 minutes


Artificial intelligence (AI) has long been touted as a game changer for pharma, so why are there so few examples of AI-driven drugs on the market?

In this webinar, we’ll explore the structural roadblocks that are impeding drug discovery programs, and discuss how FAIR data principles and open standards can accelerate speed to market and enable enterprise-wise digital transformation. In addition, we will consider pragmatic steps your lab can take today to harmonize your data inputs and automate data capture.

Brought to you by:


Dr. Haydn Boehm
Head of Commercial Marketing,
Connected Lab, MilliporeSigma
Kelly McSweeney
Contributing Editor,
C&EN Media Group


*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy.

© 2021 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy